Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 10—October 2023
Research

Posttransfusion Sepsis Attributable to Bacterial Contamination in Platelet Collection Set Manufacturing Facility, United States

Ian Kracalik, Alyssa G. Kent, Carlos H. Villa, Paige Gable, Pallavi Annambhotla, Gillian McAllister, Deborah Yokoe, Charles R. Langelier, Kelly Oakeson, Judith Noble-Wang, Orieji Illoh, Alison Laufer Halpin, Anne F. Eder, and Sridhar V. BasavarajuComments to Author 
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (I. Kracalik, A.G. Kent, P. Gable, P. Annambhotla, G. McAllister, J. Noble-Wang, A.L. Halpin, S.V. Basavaraju); Food and Drug Administration, Silver Spring, Maryland, USA (C.H. Villa, O. Illoh, A.F. Eder); University of California San Francisco School of Medicine, San Francisco, California, USA (D. Yokoe, C.R. Langelier); Utah Department of Health, Salt Lake City, Utah, USA (K. Oakeson)

Main Article

Figure 1

Investigation timeline of transfusion-transmitted sepsis cases and key events for bacterial contamination in platelet collection set manufacturing facilities, United States, 2018–2022. CDC, Centers for Disease Control and Prevention; EIN, Emerging Infections Network; Epi-X, Epidemic Information Exchange; FDA, Food and Drug Administration; MMWR, report published in Morbidity and Mortality Weekly Report (9).

Figure 1. Investigation timeline of transfusion-transmitted sepsis cases and key events for bacterial contamination in platelet collection set manufacturing facilities, United States, 2018–2022. CDC, Centers for Disease Control and Prevention; EIN, Emerging Infections Network; Epi-X, Epidemic Information Exchange; FDA, Food and Drug Administration; MMWR, report published in Morbidity and Mortality Weekly Report (9).

Main Article

References
  1. Wagner  SJ, Friedman  LI, Dodd  RY. Transfusion-associated bacterial sepsis. Clin Microbiol Rev. 1994;7:290–302. DOIPubMedGoogle Scholar
  2. Eder  AF, Kennedy  JM, Dy  BA, Notari  EP, Weiss  JW, Fang  CT, et al.; American Red Cross Regional Blood Centers. Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004-2006). Transfusion. 2007;47:1134–42. DOIPubMedGoogle Scholar
  3. Kuehnert  MJ, Roth  VR, Haley  NR, Gregory  KR, Elder  KV, Schreiber  GB, et al. Transfusion-transmitted bacterial infection in the United States, 1998 through 2000. Transfusion. 2001;41:1493–9. DOIPubMedGoogle Scholar
  4. Free  RJ, Sapiano  MRP, Chavez Ortiz  JL, Stewart  P, Berger  J, Basavaraju  SV. Continued stabilization of blood collections and transfusions in the United States: findings from the 2021 National Blood Collection and Utilization Survey. Transfusion. 2023;trf.17360.
  5. Hong  H, Xiao  W, Lazarus  HM, Good  CE, Maitta  RW, Jacobs  MR. Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance. Blood. 2016;127:496–502. DOIPubMedGoogle Scholar
  6. Fenwick  AJ, Gehrie  EA, Marshall  CE, Tobian  AAR, Shrestha  R, Kacker  S, et al. Secondary bacterial culture of platelets to mitigate transfusion-associated sepsis: A 3-year analysis at a large academic institution. Transfusion. 2020;60:2021–8. DOIPubMedGoogle Scholar
  7. Brecher  ME, Hay  SN. Bacterial contamination of blood components. Clin Microbiol Rev. 2005;18:195–204. DOIPubMedGoogle Scholar
  8. US Food and Drug Administration. Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion. 2020 [cited 2023 Aug 2]. https://www.fda.gov/media/123448/download
  9. Jones  SA, Jones  JM, Leung  V, Nakashima  AK, Oakeson  KF, Smith  AR, et al. Sepsis attributed to bacterial contamination of platelets associated with a potential common source—multiple states, 2018. MMWR Morb Mortal Wkly Rep. 2019;68:519–23. DOIPubMedGoogle Scholar
  10. US Food and Drug Administration. Important information for blood establishments and transfusion services regarding bacterial contamination of platelets for transfusion. 2021 [cited 2023 Aug 2]. https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/important-information-blood-establishments-and-transfusion-services-regarding-bacterial
  11. US Food and Drug Administration. Important information for blood establishments and transfusion services regarding bacterial contamination of platelets for transfusion. 2022 [cited 2023 Aug 2]. https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/important-information-blood-establishments-and-transfusion-services-regarding-bacterial-0
  12. Stanton  RA, Vlachos  N, de Man  TJ, Lawsin  A, Halpin  AL. Development and application of QuAISAR-H: a bioinformatics pipeline for short read sequences of healthcare-associated pathogens. Presented at: ASM Conference on Rapid Applied Microbial Next Generation Sequencing and Bioinformatics Pipelines; Tyson Falls, VA, USA; September 25, 2018.
  13. Nevala-Plagemann  C, Powers  P, Mir-Kasimov  M, Rose  R. A fatal case of septic shock secondary to Acinetobacter bacteremia acquired from a platelet transfusion. Case Rep Med. 2019;2019:3136493. DOIPubMedGoogle Scholar
  14. Fridey  JL, Stramer  SL, Nambiar  A, Moayeri  M, Bakkour  S, Langelier  C, et al. Sepsis from an apheresis platelet contaminated with Acinetobacter calcoaceticus/baumannii complex bacteria and Staphylococcus saprophyticus after pathogen reduction. Transfusion. 2020;60:1960–9. DOIPubMedGoogle Scholar
  15. Fadeyi  EA, Wagner  SJ, Goldberg  C, Lu  T, Young  P, Bringmann  PW, et al. Fatal sepsis associated with a storage container leak permitting platelet contamination with environmental bacteria after pathogen reduction. Transfusion. 2021;61:641–8. DOIPubMedGoogle Scholar
  16. Food and Drug Administration. FDA dashboards. 2023 [cited 2023 Jan 31]. https://datadashboard.fda.gov/ora/firmprofile.htm?FEIi=2627511
  17. Eder  AF, Dy  BA, DeMerse  B, Wagner  SJ, Stramer  SL, O’Neill  EM, et al. Apheresis technology correlates with bacterial contamination of platelets and reported septic transfusion reactions. Transfusion. 2017;57:2969–76. DOIPubMedGoogle Scholar
  18. Perez  P, Salmi  LR, Folléa  G, Schmit  JL, de Barbeyrac  B, Sudre  P, et al.; BACTHEM Group; French Haemovigilance Network. Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM Case-Control Study. Transfusion. 2001;41:862–72. DOIPubMedGoogle Scholar
  19. LaVerda  D, Shinefeld  L, Best  N, Lisitu  J, Tambolleo  G, Vallejo  YR. Evaluation of an improved rapid bacterial assay with untreated and pathogen-reduced platelets: Detection of Acinetobacter strains. Transfusion. 2021;61:2710–7. DOIPubMedGoogle Scholar
  20. Kundrapu  S, Srivastava  S, Good  CE, Lazarus  HM, Maitta  RW, Jacobs  MR. Bacterial contamination and septic transfusion reaction rates associated with platelet components before and after introduction of primary culture: experience at a US Academic Medical Center 1991 through 2017. Transfusion. 2020;60:974–85. DOIPubMedGoogle Scholar
  21. Haass  KA, Sapiano  MRP, Savinkina  A, Kuehnert  MJ, Basavaraju  SV. Transfusion-transmitted infections reported to the national healthcare safety network hemovigilance module. Transfus Med Rev. 2019;33:84–91. DOIPubMedGoogle Scholar
  22. Heltberg  O, Skov  F, Gerner-Smidt  P, Kolmos  HJ, Dybkjaer  E, Gutschik  E, et al. Nosocomial epidemic of Serratia marcescens septicemia ascribed to contaminated blood transfusion bags. Transfusion. 1993;33:221–7. DOIPubMedGoogle Scholar
  23. Cloutier  M, De Korte  D; ISBT Transfusion-Transmitted Infectious Diseases Working Party, Subgroup on Bacteria. Residual risks of bacterial contamination for pathogen-reduced platelet components. Vox Sang. 2022;117:879–86. DOIPubMedGoogle Scholar
  24. Gammon  RR, Reik  RA, Stern  M, Vassallo  RR, Waxman  DA, Young  PP, et al. Acquired platelet storage container leaks and contamination with environmental bacteria: A preventable cause of bacterial sepsis. Transfusion. 2022;62:641–50. DOIPubMedGoogle Scholar
  25. Crawford  E, Kamm  J, Miller  S, Li  LM, Caldera  S, Lyden  A, et al. Investigating transfusion-related sepsis using culture-independent metagenomic sequencing. Clin Infect Dis. 2020;71:1179–85. DOIPubMedGoogle Scholar
  26. Wong  D, Nielsen  TB, Bonomo  RA, Pantapalangkoor  P, Luna  B, Spellberg  B. Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges. Clin Microbiol Rev. 2017;30:409–47. DOIPubMedGoogle Scholar
  27. Lawal  OU, Fraqueza  MJ, Bouchami  O, Worning  P, Bartels  MD, Gonçalves  ML, et al. Foodborne origin and local and global spread of Staphylococcus saprophyticus causing human urinary tract infections. Emerg Infect Dis. 2021;27:880–93. DOIPubMedGoogle Scholar
  28. Lawal  OU, Barata  M, Fraqueza  MJ, Worning  P, Bartels  MD, Goncalves  L, et al. Staphylococcus saprophyticus from clinical and environmental origins have distinct biofilm composition. Front Microbiol. 2021;12:663768. DOIPubMedGoogle Scholar
  29. Gedefie  A, Demsis  W, Ashagrie  M, Kassa  Y, Tesfaye  M, Tilahun  M, et al. Acinetobacter baumannii biofilm formation and its role in disease pathogenesis: a review. Infect Drug Resist. 2021;14:3711–9. DOIPubMedGoogle Scholar
  30. Kerantzas  CA, Merwede  J, Snyder  EL, Hendrickson  JE, Tormey  CA, Kazmierczak  BI, et al. Assessment of polymicrobial interactions in bacterial isolates from transfused platelet units associated with sepsis. Transfusion. 2022;62:2458–63. DOIPubMedGoogle Scholar
  31. Greco-Stewart  VS, Brown  EE, Parr  C, Kalab  M, Jacobs  MR, Yomtovian  RA, et al. Serratia marcescens strains implicated in adverse transfusion reactions form biofilms in platelet concentrates and demonstrate reduced detection by automated culture. Vox Sang. 2012;102:212–20. DOIPubMedGoogle Scholar
  32. Jacobs  MR, Good  CE, Lazarus  HM, Yomtovian  RA. Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets. Clin Infect Dis. 2008;46:1214–20. DOIPubMedGoogle Scholar
  33. Centers for Disease Control and Prevention. FY23 broad agency announcement notice 75D301–23-R-72545. 2023 [cited 2023 Jan 31]. https://sam.gov/opp/15229982f7c348f69fd35e9a0add8aba/view

Main Article

Page created: August 02, 2023
Page updated: September 20, 2023
Page reviewed: September 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external